Literature DB >> 1281312

Effects of atrionatriuretic factor on Ca2+ current and Cai-independent transient outward K+ current in human atrial cells.

B Le Grand1, E Deroubaix, J P Couétil, E Coraboeuf.   

Abstract

The effect of 10 nM atrial natriuretic peptide (ANF) on macroscopic L-type calcium current, ICa, and calcium-independent outward potassium current, Ilo, were studied in myocytes isolated from human atrial trabeculae using the whole-cell-recording patch-clamp technique. When cells were dialysed with pipette media containing 0.2 mM GTP, ANF reduced ICa by 37.81% +/- 5.4% at +20 mV and Ilo by 21.72% +/- 3.68% at +60 mV in a reversible manner. When ICa was increased by beta-adrenoreceptor stimulation (0.1 microM isoproterenol) or by the phosphodiesterase inhibitor isobutylmethylxanthine (10 microM) ANF reduced ICa by 24.99 +/- 3.4% and by 39.9 +/- 6.3% respectively. In cells dialysed with GTP-free pipette media, ANF increased ICa markedly (39.8% +/- 7%) and reversibly, whereas it still depressed Ilo (18.92% +/- 2%). Addition of 0.2 mM GTP[gamma S] to the pipette solution in the absence of GTP increased ICa, decreased Ilo and suppressed the effect of ANF on both ICa and Ilo. It is suggested that activation of the ANF receptor in human atrial cells reduces ICa via guanylate-cyclase-dependent cGMP production, increases ICa via Gs protein activation and decreases Ilo via Gi protein activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281312     DOI: 10.1007/BF00370260

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  28 in total

1.  ATP-dependent activation of atrial muscarinic K+ channels in the absence of agonist and G-nucleotides.

Authors:  H Heidbüchel; G Callewaert; J Vereecke; E Carmeliet
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

2.  Atrionatriuretic peptide transforms cardiac sodium channels into calcium-conducting channels.

Authors:  L A Sorbera; M Morad
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

Review 3.  Diverse biological actions of atrial natriuretic peptide.

Authors:  B M Brenner; B J Ballermann; M E Gunning; M L Zeidel
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

4.  Potentiation by cyclic GMP of beta-adrenergic effect on Ca2+ current in guinea-pig ventricular cells.

Authors:  K Ono; W Trautwein
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

5.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

Review 6.  Cyclic guanosine monophosphate as a mediator of vasodilation.

Authors:  F Murad
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

7.  Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.

Authors:  A Kurtz; R Della Bruna; J Pfeilschifter; R Taugner; C Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.

Authors:  M Chinkers; D L Garbers; M S Chang; D G Lowe; H M Chin; D V Goeddel; S Schulz
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

9.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

Authors:  P Hamet; J Tremblay; S C Pang; R Garcia; G Thibault; J Gutkowska; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

10.  Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.

Authors:  S A Waldman; R M Rapoport; F Murad
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

View more
  15 in total

1.  Cyclic GMP-mediated inhibition of L-type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells.

Authors:  N Tohse; H Nakaya; Y Takeda; M Kanno
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

2.  cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.

Authors:  M Rivet-Bastide; G Vandecasteele; S Hatem; I Verde; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

3.  Natriuretic peptide immunoreactivity in nerve structures and Purkinje fibres of human, pig and sheep hearts.

Authors:  M Hansson; A Eriksson; S Forsgren
Journal:  Histochem J       Date:  1997-04

4.  Comparative study of cardiac electrophysiological effects of atrial natriuretic peptide.

Authors:  V Kecskemeti; P Pacher; C Pankucsi; P Nanasi
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 5.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

6.  High concentrations of atrial natriuretic peptide and brain natriuretic peptide in rat pericardial fluid and their reduction by reserpine in vivo.

Authors:  R Klemola; M Laine; M Weckström; O Vuolteenaho; H Ruskoaho; P Huttunen; J Leppäluoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

7.  Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.

Authors:  Ambili Menon; Liang Hong; Eleonora Savio-Galimberti; Arvind Sridhar; Seock-Won Youn; Meihong Zhang; Kaylen Kor; Marcia Blair; Sabina Kupershmidt; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2019-05-08       Impact factor: 5.000

8.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

9.  Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

Authors:  Denice M Hodgson-Zingman; Margaret L Karst; Leonid V Zingman; Denise M Heublein; Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Mariza de Andrade; John C Burnett; Timothy M Olson
Journal:  N Engl J Med       Date:  2008-07-10       Impact factor: 91.245

10.  Atrial natriuretic peptide regulates Ca channel in early developmental cardiomyocytes.

Authors:  Lin Miao; Min Wang; Wen-Xuan Yin; Qi Yuan; Ying-Xiao Chen; Bernd Fleischmann; Jürgen Hescheler; Guangju Ji
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.